Pardes Biosciences, Inc.
PRDSDelisted Aug 31, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822711
Pardes Biosciences, Inc. was delisted on Aug 31, 2023; its insiders filed their last Form 4 on Aug 31, 2023; 59 institutions reported holding it in 13F filings for Q2 2023, worth $63.9M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Pardes Biosciences, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 57
- +16 vs. Q4 2021
- Shares held
- 39.1M
- +4.07M (+11.6%) vs. Q4 2021
- Total value
- $282.3M
- −$290.7M (−50.7%) vs. Q4 2021
- New holders
- 21
- 13 more added
- Sold out
- 5
- 13 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRDS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 1 | $66.7K |
| Q2 2023 | 59 | $63.9M |
| Q1 2023 | 60 | $48.6M |
| Q4 2022 | 64 | $63.8M |
| Q3 2022 | 67 | $87.2M |
| Q2 2022 | 68 | $143.7M |
| Q1 2022 | 57 | $282.3M |
| Q4 2021 | 41 | $573.0M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Pardes Biosciences, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Foresite Capital Management V, LLC | 9,400,515 | $67.9M | 27.72% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 6,175,038 | $44.6M | 0.97% | +3,048,000+97.5% | Added |
| Foresite Capital Opportunity Management V, LLC | 5,227,307 | $37.7M | 52.85% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 2,112,411 | $15.3M | 0.00% | +2,112,411 | New |
| Frazier Life Sciences Management, L.P. | 2,081,007 | $15.0M | 1.28% | +2,081,007 | New |
| Price T Rowe Associates Inc | 1,816,559 | $13.1M | 0.00% | −1,395,916−43.5% | Reduced |
| Lynx1 Capital Management LP | 1,642,834 | $11.9M | 11.01% | +1,241,241+309.1% | Added |
| Platinum Investment Management Ltd | 1,250,678 | $9.03M | 0.28% | +163,608+15.1% | Added |
| Vanguard Group Inc | 985,974 | $7.12M | 0.00% | +985,974 | New |
| Arena Capital Advisors, LLC- CA | 851,281 | $6.15M | 0.93% | −336,168−28.3% | Reduced |
| PFM Health Sciences, LP | 730,357 | $5.27M | 0.20% | +368,829+102.0% | Added |
| Chescapmanager LLC | 586,026 | $4.23M | 0.91% | −385,088−39.7% | Reduced |
| Janus Henderson Group PLC | 454,895 | $3.29M | 0.00% | −115,665−20.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 450,000 | $3.25M | 0.01% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 432,134 | $3.12M | 0.01% | +294,900+214.9% | Added |
| DAFNA Capital Management LLC | 421,157 | $3.04M | 0.79% | +187,657+80.4% | Added |
| Franklin Resources Inc | 400,000 | $2.89M | 0.00% | 00.0% | Unchanged |
| Harvard Management Co Inc | 400,000 | $2.89M | 0.29% | 00.0% | Unchanged |
| BlackRock Inc. | 343,787 | $2.48M | 0.00% | +343,787 | New |
| Ikarian Capital, LLC | 323,934 | $2.34M | 0.71% | −76,066−19.0% | Reduced |
| Sio Capital Management, LLC | 315,564 | $2.28M | 0.92% | +3,126+1.0% | Added |
| Altium Capital Management LP | 253,000 | $1.83M | 0.64% | +53,000+26.5% | Added |
| Millennium Management LLC | 245,168 | $1.77M | 0.00% | +10,770+4.6% | Added |
| TCG Crossover Management, LLC | 229,100 | $1.65M | 0.66% | +229,100 | New |
| Alyeska Investment Group, L.P. | 225,000 | $1.63M | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 222,988 | $1.61M | 0.00% | +222,988 | New |
| Wellington Management Group LLP | 194,868 | $1.41M | 0.00% | −13,010−6.3% | Reduced |
| EcoR1 Capital, LLC | 200,000 | $1.39M | 0.04% | −1,397,139−87.5% | Reduced |
| Monashee Investment Management LLC | 158,196 | $1.14M | 0.33% | −341,804−68.4% | Reduced |
| Charles Schwab Investment Management Inc | 146,804 | $1.06M | 0.00% | +146,804 | New |
| Altai Capital Management, L.P. | 100,000 | $722.0K | 0.49% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 85,000 | $614.0K | 0.30% | +35,000+70.0% | Added |
| Manufacturers Life Insurance Company, The | 82,075 | $612.9K | 0.00% | +82,075 | New |
| State Street Corp | 82,420 | $595.0K | 0.00% | +82,420 | New |
| TD Asset Management Inc | 78,505 | $567.0K | 0.00% | −3,993−4.8% | Reduced |
| Harvest Management LLC | 50,379 | $364.0K | 0.43% | +30,379+151.9% | Added |
| Northern Trust Corp | 50,096 | $362.0K | 0.00% | +50,096 | New |
| ExodusPoint Capital Management, LP | 49,699 | $359.0K | 0.01% | +49,699 | New |
| Cubist Systematic Strategies, LLC | 46,300 | $334.0K | 0.00% | +44,094+1,998.8% | Added |
| Barclays PLC | 42,800 | $309.0K | 0.00% | +42,800 | New |
| Boothbay Fund Management, LLC | 33,772 | $244.0K | 0.01% | −10,425−23.6% | Reduced |
| D. E. Shaw & Co., Inc. | 27,273 | $197.0K | 0.00% | −10,766−28.3% | Reduced |
| Squarepoint Ops LLC | 22,832 | $165.0K | 0.00% | +22,832 | New |
| Bank of America Corp | 17,550 | $127.0K | 0.00% | +17,550 | New |
| Jane Street Group, LLC | 16,771 | $121.0K | 0.00% | +16,771 | New |
| Dynamic Technology Lab Private Ltd | 14,601 | $105.0K | 0.01% | +14,601 | New |
| Bank of New York Mellon Corp | 10,337 | $75.0K | 0.00% | +10,337 | New |
| Citigroup Inc | 2,831 | $20.0K | 0.00% | +2,831 | New |
| Morgan Stanley | 2,763 | $20.0K | 0.00% | +2,763 | New |
| Penserra Capital Management LLC | 2,542 | $18.0K | 0.00% | −775−23.4% | Reduced |
| Royal Bank of Canada | 1,823 | $13.0K | 0.00% | +1,823 | New |
| Tower Research Capital LLC (TRC) | 1,393 | $10.0K | 0.00% | +1,112+395.7% | Added |
| American Portfolios Advisors | 1,000 | $7.22K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 1,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Ovata Capital Management Ltd | 500 | $4.00K | 0.00% | +500 | New |
| Wells Fargo & Company | 323 | $2.00K | 0.00% | −18,944−98.3% | Reduced |
| UBS Group AG | 150 | $1.00K | 0.00% | 00.0% | Unchanged |
| Frazier Management LLC | 0 | $0 | 0.00% | −2,457,507−100.0% | Sold out |
| JS Capital Management LLC | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −69,962−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −34−100.0% | Sold out |